News

Pfizer’s announcement that it will stop developing its oral weight-loss drug gave shares of Wegovy maker Novo Nordisk and ...
U.S. regulators are trying to shut down the industry for compounded weight-loss drugs, which could result in higher costs or ...
Popular weight loss drugs, like Ozempic and Wegovy, work by slowing digestion and making people feel full longer. But it is becoming clear to researchers that these drugs also work in the brain to ...
Certain foods can worsen GI side effects from GLP-1 durgs. Learn which foods to avoid and which to choose instead.
Fourteen medical spas across Ohio are accused of misleading customers about their versions of weight loss drugs ...
It's not clear which children would benefit, when to start the drugs and, once started, whether children would have to stay ...
People taking GLP-1s consumed less processed food, although they still craved it. As a growing number of people using ...
The FDA and the manufacturer of Ozempic, Novo Nordisk are urging patients, doctors and pharmacies to check their Ozempic ...
President Trump directed his administration to help states import drugs from Canada. But a proposal to alter a Medicare ...
The maker of Ozempic and Wegovy found fake 1-milligram injections were being distributed through unauthorized sellers.
Blockbuster weight loss meds like Ozempic and Wegovy are now linked to a rare eye disease that can lead to blindness.
Shares of weight-loss drugmakers Novo Nordisk A/S and Eli Lilly and Co. got a nice lift Monday, after a potential competitor decided to cancel development of its GLP-1 obesity drug. “We continue ...